A Phytosterolemic Mixture of Sterols Inhibits Cholesterol Synthesis, Esterification, and Low-Density Lipoprotein Receptor mRNA Abundance in HepG2 Cells

Lipids. 2020 Mar;55(2):193-198. doi: 10.1002/lipd.12223. Epub 2020 Feb 17.

Abstract

HepG2 cells were incubated with a 16.5:1.7:1 ratio of cholesterol:sitosterol:campesterol (CSC), a ratio of the major sterols observed in the plasma of phytosterolemia patients, or with cholesterol alone in combination with [14 C]acetate for 24 h and the radioactivity incorporated into lipids determined. Cells incubated with CSC exhibited a 40% reduction in cholesterol esterification (p < 0.05) compared to cells incubated with cholesterol alone. In addition, a 17.5-fold reduction (p < 0.05) in total cholesterol (cholesterol plus cholesteryl ester) synthesis from [14 C]acetate was observed in cells incubated with CSC compared to cholesterol alone. Low-density lipoprotein receptor (LDLR) mRNA abundance was lower in cells incubated with CSC compared to cells incubated with cholesterol alone. Our results suggest that incubation of HepG2 cells with a ratio of sterols that mimic the plasma concentration seen in phytosterolemia patients reduces cholesterol esterification, total cholesterol synthesis, and inhibits LDLR mRNA abundance. We suggest that future cell and animal-based work on phytostosterolemia might employ this methodology to serve as a novel paradigm of the disease.

Keywords: Campesterol; Cholesterol; Cholesteryl ester; Low-density lipoprotein receptor; Phytosterolemia; Sitosterol; Triacylglycerol.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carbon Radioisotopes / pharmacology
  • Cholesterol / analogs & derivatives*
  • Cholesterol / pharmacology*
  • Cholesterol Esters / metabolism
  • Down-Regulation
  • Gene Expression Profiling
  • Gene Expression Regulation / drug effects
  • Hep G2 Cells
  • Humans
  • Hypercholesterolemia / genetics*
  • Hypercholesterolemia / metabolism
  • Intestinal Diseases / genetics*
  • Intestinal Diseases / metabolism
  • Lipid Metabolism, Inborn Errors / genetics*
  • Lipid Metabolism, Inborn Errors / metabolism
  • Models, Biological
  • Phytosterols / adverse effects*
  • Phytosterols / genetics
  • Phytosterols / metabolism
  • Phytosterols / pharmacology
  • Receptors, LDL / genetics*
  • Sitosterols / pharmacology*

Substances

  • Carbon Radioisotopes
  • Cholesterol Esters
  • LDLR protein, human
  • Phytosterols
  • Receptors, LDL
  • Sitosterols
  • campesterol
  • gamma-sitosterol
  • Carbon-14
  • Cholesterol

Supplementary concepts

  • Sitosterolemia